Jennifer E Johnson1, Richard Jones2, Ted Miller3, Ivan Miller4, Barbara Stanley5, Greg Brown6, Sarah A Arias7, Louis Cerbo8, Julie Rexroth9, Holly Fitting10, Danis Russell11, Sheryl Kubiak12, Michael Stein13, Christopher Matkovic14, Shirley Yen15, Brandon Gaudiano16, Lauren M Weinstock17. 1. Michigan State University College of Human Medicine, 200 East 1(st) St Room 366, Flint, MI 48503, United States of America. Electronic address: JJohns@msu.edu. 2. Brown University Warren Alpert Medical School, 700 Butler Drive, Providence, RI 02906, United States of America. Electronic address: Richard_Jones@brown.edu. 3. Pacific Institute for Research and Evaluation, 11720 Beltsville Drive, Suite 909, Calverton, MD 20705, United States of America. Electronic address: Miller@pire.org. 4. Brown University Warren Alpert Medical School, 345 Blackstone Blvd, Providence, RI 02906, United States of America. Electronic address: Ivan_Miller_iii@brown.edu. 5. Columbia University, 1051 Riverside Drive, Unit 42, New York, NY 10032, United States of America. Electronic address: Bhs2@columbia.edu. 6. University of Pennsylvania Perelman School of Medicine, 3535 Market Street, Room 2032, Philadelphia, PA 19104, United States of America. Electronic address: gregbrow@mail.med.upenn.edu. 7. Brown University Warren Alpert Medical School and Butler Hospital, 345 Blackstone Blvd, Providence, RI 02906, United States of America. 8. Rhode Island Department of Corrections, 1375 Pontiac Avenue, Cranston, RI 029020, United States of America. Electronic address: Louis.Cerbo@bhddh.ri.gov. 9. Genesee County Jail and Corizon Health, 1002 South Saginaw Street, Flint, MI 48502, United States of America. Electronic address: Julie.Rexroth@corizonhealth.com. 10. The Providence Center, 528 N. Main Street, Providence, RI, 02904, United States of America. Electronic address: hfitting@provctr.org. 11. Genesee Health System, 420 West 5(th) Avenue, Flint, MI 48503, United States of America. Electronic address: drussell@ghs.org. 12. Wayne State University School of Social Work, 5447 Woodward Avenue, Detroit, MI 48202, United States of America. Electronic address: spk@wayne.edu. 13. Boston University, 715 Albany Street, Talbot Building T2W, Boston, MA 02118, United States of America. Electronic address: mdstein@bu.edu. 14. Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, United States of America. Electronic address: Christopher_Matkovic@brown.edu. 15. Brown University Warren Alpert Medical School, 700 Butler Drive, Providence, RI 02906, United States of America. Electronic address: Shirley_Yen_PhD@brown.edu. 16. Brown University Warren Alpert Medical School and Butler Hospital, 345 Blackstone Blvd, Providence, RI 02906, United States of America. Electronic address: Brandon_Gaudiano@brown.edu. 17. Brown University Warren Alpert Medical School, 700 Butler Drive, Providence, RI 02906, United States of America. Electronic address: Lauren_Weinstock@brown.edu.
Abstract
PURPOSE: This article describes the protocol for a randomized effectiveness and cost-effectiveness trial of Stanley and Brown's Safety Planning Intervention (SPI) during pretrial jail detention to reduce post-release suicide events (suicide attempts, suicide behaviors, and suicide-related hospitalizations). BACKGROUND: With 10 million admissions per year and short stays (often days), U.S. jails touch many individuals at risk for suicide, providing an important opportunity for suicide prevention that is currently being missed. This study (N = 800) is the first randomized evaluation of an intervention to reduce suicide risk in the vulnerable year after jail release. Given that roughly 10% of all suicides in the U.S. with known circumstances occur in the context of a criminal legal stressor, reducing suicide risk in the year after arrest and jail detention could have a noticeable impact on national suicide rates. DESIGN: Pretrial jail detainees at risk for suicide were randomized to SPI during jail detention plus post-release phone follow-up or to enhanced Standard Care. Outcomes assessed through 12 months post-release include suicide events, suicide attempts, weeks of active suicide ideation, severity of suicide ideation, time to first event, psychiatric symptoms, functioning, and cost-effectiveness. Methods accommodate short jail stays and maximize trial safety and follow-up in a large sample with severe suicide risk, access to lethal means including substances and firearms, high rates of psychiatric illness, and unstable circumstances. CONCLUSION: Adequate funding was important to create the infrastructure needed to run this large trial cleanly. We encourage funders to provide adequate resources to ensure clean, well-run trials.
PURPOSE: This article describes the protocol for a randomized effectiveness and cost-effectiveness trial of Stanley and Brown's Safety Planning Intervention (SPI) during pretrial jail detention to reduce post-release suicide events (suicide attempts, suicide behaviors, and suicide-related hospitalizations). BACKGROUND: With 10 million admissions per year and short stays (often days), U.S. jails touch many individuals at risk for suicide, providing an important opportunity for suicide prevention that is currently being missed. This study (N = 800) is the first randomized evaluation of an intervention to reduce suicide risk in the vulnerable year after jail release. Given that roughly 10% of all suicides in the U.S. with known circumstances occur in the context of a criminal legal stressor, reducing suicide risk in the year after arrest and jail detention could have a noticeable impact on national suicide rates. DESIGN: Pretrial jail detainees at risk for suicide were randomized to SPI during jail detention plus post-release phone follow-up or to enhanced Standard Care. Outcomes assessed through 12 months post-release include suicide events, suicide attempts, weeks of active suicide ideation, severity of suicide ideation, time to first event, psychiatric symptoms, functioning, and cost-effectiveness. Methods accommodate short jail stays and maximize trial safety and follow-up in a large sample with severe suicide risk, access to lethal means including substances and firearms, high rates of psychiatric illness, and unstable circumstances. CONCLUSION: Adequate funding was important to create the infrastructure needed to run this large trial cleanly. We encourage funders to provide adequate resources to ensure clean, well-run trials.
Authors: Helena Chmura Kraemer; George A Morgan; Nancy L Leech; Jeffrey A Gliner; Jerry J Vaske; Robert J Harmon Journal: J Am Acad Child Adolesc Psychiatry Date: 2003-12 Impact factor: 8.829
Authors: Barbara Stanley; Gregory K Brown; Glenn W Currier; Chelsea Lyons; Megan Chesin; Kerry L Knox Journal: Am J Public Health Date: 2015-06-11 Impact factor: 9.308
Authors: Jennifer E Johnson; Yael Chatav Schonbrun; Jessica E Nargiso; Caroline C Kuo; Ruth T Shefner; Collette A Williams; Caron Zlotnick Journal: Int J Prison Health Date: 2013
Authors: Ivan W Miller; Carlos A Camargo; Sarah A Arias; Ashley F Sullivan; Michael H Allen; Amy B Goldstein; Anne P Manton; Janice A Espinola; Richard Jones; Kohei Hasegawa; Edwin D Boudreaux Journal: JAMA Psychiatry Date: 2017-06-01 Impact factor: 21.596
Authors: D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar Journal: J Clin Psychiatry Date: 1998 Impact factor: 4.384
Authors: Edwin D Boudreaux; Ivan Miller; Amy B Goldstein; Ashley F Sullivan; Michael H Allen; Anne P Manton; Sarah A Arias; Carlos A Camargo Journal: Contemp Clin Trials Date: 2013-05-22 Impact factor: 2.226
Authors: Jennifer E Johnson; Yael Chatav Schonbrun; Bradley Anderson; Christine Timko; Michael D Stein Journal: Drug Alcohol Depend Date: 2021-08-28 Impact factor: 4.852
Authors: Jennifer E Johnson; Ann B Price; Alla Sikorskii; Kent D Key; Brandon Taylor; Susan Lamphere; Christine Huff; Morgan Cinader; Caron Zlotnick Journal: BMJ Open Date: 2022-04-19 Impact factor: 3.006